The DOI matches its Crossref record.
Usefulness of gastric cancer screening using the serum pepsinogen test method
Abstract
OBJECTIVE: The measurement of serum pepsinogen has recently gained attention as a candidate for a new screening test for gastric cancer. This method is particularly attractive given its lower cost and simplicity to administer relative to photofluorography. To compare the accuracy between the two screening methods, and to elucidate the usefulness of the serum pepsinogen test method, we performed this study. METHODS: Mass screening for gastric cancer was performed using both the x-ray and pepsinogen test methods simultaneously on 286 company employees. The number of tests conducted was 5567 in total. The mean age was 48 yr in both men and women. Informed consent was taken individually. Fasting blood samples were collected, and measurement of the serum pepsinogen concentration was carried out by immunoradiometric assay. RESULTS: The percentage of those screened, who needed further examination was 11.7% for the x-ray method and 23.6% for the pepsinogen test method. The percentage of those who required further investigation, as the second step of screening, using endoscopy, was 55.4% for the x-ray method and 51.9% for the pepsinogen test method, respectively. Ten gastric cancers were detected in total. The incidence was 0.05% in the x-ray method and 0.18% in the pepsinogen test method. The rate of early gastric cancer to advanced gastric cancer was 9 to 1, that is, 90% were in the early stages. The positive predictive value was 0.8% in the x-ray method and 1.4% in the pepsinogen test method. CONCLUSIONS: The pepsinogen test method can be used as a screening test for high-risk subjects with atrophic gastritis, rather than as a tool for cancer itself. Systemic endoscopic surveillance of this group is also useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Screening for gastric cancer in Asia: current evidence and practice
Leung, W. K., Wu, M.-S., Kakugawa, Y., Kim, J. J., Yeoh, K.-G., Goh, K. L., Wu, K.-C., Wu, D.-C., Sollano, J., Kachintorn, U., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70072-x · Cited by 822
Dinis-Ribeiro, M., Areia, M., de Vries, A., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., et al. (2012) · Endoscopy · doi:10.1055/s-0031-1291491 · Cited by 680
Self-citationAsia–Pacific consensus guidelines on gastric cancer prevention
Fock, K. M., Talley, N., Moayyedi, P., Hunt, R., Azuma, T., Sugano, K., Xiao, S. D., Lam, S. K., Goh, K. L., Chiba, T., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05314.x · Cited by 354
Metadata
- Authors
- Miki, K.
- Venue
- The American Journal of Gastroenterology
- Published
- 2003-04
- Volume
- 98
- Issue
- 4
- Pages
- 735-739
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2070881516
- Cited by
- 199
- References
- 0
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Usefulness of gastric cancer screening using the serum pepsinogen test method. https://app.cochat.ai/papers/10.1016/s0002-9270(03)00128-x
- The paper
- Miki, K. (2003). Usefulness of gastric cancer screening using the serum pepsinogen test method. The American Journal of Gastroenterology. https://doi.org/10.1016/s0002-9270(03)00128-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.